Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials

In randomized clinical trials of subarachnoid hemorrhage (SAH) in which the primary clinical outcomes are ordinal, it has been common practice to dichotomize the ordinal outcome scale into favorable versus unfavorable outcome. Using this strategy may increase sample sizes by reducing statistical pow...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurosurgery 2013-01, Vol.118 (1), p.3-12
Hauptverfasser: Ilodigwe, Don, Murray, Gordon D, Kassell, Neal F, Torner, James, Kerr, Richard S C, Molyneux, Andrew J, Macdonald, R Loch
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 12
container_issue 1
container_start_page 3
container_title Journal of neurosurgery
container_volume 118
creator Ilodigwe, Don
Murray, Gordon D
Kassell, Neal F
Torner, James
Kerr, Richard S C
Molyneux, Andrew J
Macdonald, R Loch
description In randomized clinical trials of subarachnoid hemorrhage (SAH) in which the primary clinical outcomes are ordinal, it has been common practice to dichotomize the ordinal outcome scale into favorable versus unfavorable outcome. Using this strategy may increase sample sizes by reducing statistical power. Authors of the present study used SAH clinical trial data to determine if a sliding dichotomy would improve statistical power. Available individual patient data from tirilazad (3552 patients), clazosentan (the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage trial [CONSCIOUS-1], 413 patients), and subarachnoid aneurysm trials (the International Subarachnoid Aneurysm Trial [ISAT], 2089 patients) were analyzed. Treatment effect sizes were examined using conventional fixed dichotomy, sliding dichotomy (logical or median split methods), or proportional odds modeling. Whether sliding dichotomy affected the difference in outcomes between the several age and neurological grade groups was also evaluated. In the tirilazad data, there was no significant effect of treatment on outcome (fixed dichotomy: OR = 0.92, 95% CI 0.80-1.07; and sliding dichotomy: OR = 1.02, 95% CI 0.87-1.19). Sliding dichotomy reversed and increased the difference in outcome in favor of the placebo over clazosentan (fixed dichotomy: OR = 1.06, 95% CI 0.65-1.74; and sliding dichotomy: OR = 0.85, 95% CI 0.52-1.39). In the ISAT data, sliding dichotomy produced identical odds ratios compared with fixed dichotomy (fixed dichotomy vs sliding dichotomy, respectively: OR = 0.67, 95% CI 0.55-0.82 vs OR = 0.67, 95% CI 0.53-0.85). When considering the tirilazad and CONSCIOUS-1 groups based on age or World Federation of Neurosurgical Societies grade, no consistent effects of sliding dichotomy compared with fixed dichotomy were observed. There were differences among fixed dichotomy, sliding dichotomy, and proportional odds models in the magnitude and precision of odds ratios, but these differences were not as substantial as those seen when these methods were used in other conditions such as head injury. This finding suggests the need for different outcome scales for SAH.
doi_str_mv 10.3171/2012.9.JNS111383
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1273131104</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1273131104</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1453-b571e363e851464fdfccaa91e942166f1dd0b36ff237c0099c1f0e01bf60075d3</originalsourceid><addsrcrecordid>eNo1UDtPwzAYtJAQLYWdCXlkSfGXL3HqEVVQQBUMhTly_GiMkri1E0H59USine6ke-h0hNwAmyMUcJ8ySOdi_vq2AQBc4BmZgkBMGBc4IZcxfjEGPOPpBZmkyFBAlk_JftM47bot1U7VvvftgSrf7mQwmn67vqbW_Yz0pLpf2TvfUW-pD2NONtQP_ZgwNCrZmEhdR-NQySBV3XmnaW1aH0Itt4b2wckmXpFzO4K5PuKMfD49fiyfk_X76mX5sE7UOAyTKi_AIEezyCHjmdVWKSkFGJGlwLkFrVmF3NoUC8WYEAosMwwqyxkrco0zcvffuwt-P5jYl62LyjSN7IwfYglpgYAALButt0frULVGl7vgWhkO5ekm_AN0o2oJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1273131104</pqid></control><display><type>article</type><title>Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Ilodigwe, Don ; Murray, Gordon D ; Kassell, Neal F ; Torner, James ; Kerr, Richard S C ; Molyneux, Andrew J ; Macdonald, R Loch</creator><creatorcontrib>Ilodigwe, Don ; Murray, Gordon D ; Kassell, Neal F ; Torner, James ; Kerr, Richard S C ; Molyneux, Andrew J ; Macdonald, R Loch</creatorcontrib><description>In randomized clinical trials of subarachnoid hemorrhage (SAH) in which the primary clinical outcomes are ordinal, it has been common practice to dichotomize the ordinal outcome scale into favorable versus unfavorable outcome. Using this strategy may increase sample sizes by reducing statistical power. Authors of the present study used SAH clinical trial data to determine if a sliding dichotomy would improve statistical power. Available individual patient data from tirilazad (3552 patients), clazosentan (the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage trial [CONSCIOUS-1], 413 patients), and subarachnoid aneurysm trials (the International Subarachnoid Aneurysm Trial [ISAT], 2089 patients) were analyzed. Treatment effect sizes were examined using conventional fixed dichotomy, sliding dichotomy (logical or median split methods), or proportional odds modeling. Whether sliding dichotomy affected the difference in outcomes between the several age and neurological grade groups was also evaluated. In the tirilazad data, there was no significant effect of treatment on outcome (fixed dichotomy: OR = 0.92, 95% CI 0.80-1.07; and sliding dichotomy: OR = 1.02, 95% CI 0.87-1.19). Sliding dichotomy reversed and increased the difference in outcome in favor of the placebo over clazosentan (fixed dichotomy: OR = 1.06, 95% CI 0.65-1.74; and sliding dichotomy: OR = 0.85, 95% CI 0.52-1.39). In the ISAT data, sliding dichotomy produced identical odds ratios compared with fixed dichotomy (fixed dichotomy vs sliding dichotomy, respectively: OR = 0.67, 95% CI 0.55-0.82 vs OR = 0.67, 95% CI 0.53-0.85). When considering the tirilazad and CONSCIOUS-1 groups based on age or World Federation of Neurosurgical Societies grade, no consistent effects of sliding dichotomy compared with fixed dichotomy were observed. There were differences among fixed dichotomy, sliding dichotomy, and proportional odds models in the magnitude and precision of odds ratios, but these differences were not as substantial as those seen when these methods were used in other conditions such as head injury. This finding suggests the need for different outcome scales for SAH.</description><identifier>EISSN: 1933-0693</identifier><identifier>DOI: 10.3171/2012.9.JNS111383</identifier><identifier>PMID: 23039145</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Neuroprotective Agents - therapeutic use ; Pregnatrienes - therapeutic use ; Randomized Controlled Trials as Topic - statistics &amp; numerical data ; Statistics as Topic - methods ; Subarachnoid Hemorrhage - drug therapy ; Subarachnoid Hemorrhage - surgery ; Subarachnoid Hemorrhage - therapy ; Treatment Outcome ; Vasospasm, Intracranial - drug therapy ; Vasospasm, Intracranial - surgery ; Vasospasm, Intracranial - therapy</subject><ispartof>Journal of neurosurgery, 2013-01, Vol.118 (1), p.3-12</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1453-b571e363e851464fdfccaa91e942166f1dd0b36ff237c0099c1f0e01bf60075d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23039145$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ilodigwe, Don</creatorcontrib><creatorcontrib>Murray, Gordon D</creatorcontrib><creatorcontrib>Kassell, Neal F</creatorcontrib><creatorcontrib>Torner, James</creatorcontrib><creatorcontrib>Kerr, Richard S C</creatorcontrib><creatorcontrib>Molyneux, Andrew J</creatorcontrib><creatorcontrib>Macdonald, R Loch</creatorcontrib><title>Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials</title><title>Journal of neurosurgery</title><addtitle>J Neurosurg</addtitle><description>In randomized clinical trials of subarachnoid hemorrhage (SAH) in which the primary clinical outcomes are ordinal, it has been common practice to dichotomize the ordinal outcome scale into favorable versus unfavorable outcome. Using this strategy may increase sample sizes by reducing statistical power. Authors of the present study used SAH clinical trial data to determine if a sliding dichotomy would improve statistical power. Available individual patient data from tirilazad (3552 patients), clazosentan (the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage trial [CONSCIOUS-1], 413 patients), and subarachnoid aneurysm trials (the International Subarachnoid Aneurysm Trial [ISAT], 2089 patients) were analyzed. Treatment effect sizes were examined using conventional fixed dichotomy, sliding dichotomy (logical or median split methods), or proportional odds modeling. Whether sliding dichotomy affected the difference in outcomes between the several age and neurological grade groups was also evaluated. In the tirilazad data, there was no significant effect of treatment on outcome (fixed dichotomy: OR = 0.92, 95% CI 0.80-1.07; and sliding dichotomy: OR = 1.02, 95% CI 0.87-1.19). Sliding dichotomy reversed and increased the difference in outcome in favor of the placebo over clazosentan (fixed dichotomy: OR = 1.06, 95% CI 0.65-1.74; and sliding dichotomy: OR = 0.85, 95% CI 0.52-1.39). In the ISAT data, sliding dichotomy produced identical odds ratios compared with fixed dichotomy (fixed dichotomy vs sliding dichotomy, respectively: OR = 0.67, 95% CI 0.55-0.82 vs OR = 0.67, 95% CI 0.53-0.85). When considering the tirilazad and CONSCIOUS-1 groups based on age or World Federation of Neurosurgical Societies grade, no consistent effects of sliding dichotomy compared with fixed dichotomy were observed. There were differences among fixed dichotomy, sliding dichotomy, and proportional odds models in the magnitude and precision of odds ratios, but these differences were not as substantial as those seen when these methods were used in other conditions such as head injury. This finding suggests the need for different outcome scales for SAH.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neuroprotective Agents - therapeutic use</subject><subject>Pregnatrienes - therapeutic use</subject><subject>Randomized Controlled Trials as Topic - statistics &amp; numerical data</subject><subject>Statistics as Topic - methods</subject><subject>Subarachnoid Hemorrhage - drug therapy</subject><subject>Subarachnoid Hemorrhage - surgery</subject><subject>Subarachnoid Hemorrhage - therapy</subject><subject>Treatment Outcome</subject><subject>Vasospasm, Intracranial - drug therapy</subject><subject>Vasospasm, Intracranial - surgery</subject><subject>Vasospasm, Intracranial - therapy</subject><issn>1933-0693</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1UDtPwzAYtJAQLYWdCXlkSfGXL3HqEVVQQBUMhTly_GiMkri1E0H59USine6ke-h0hNwAmyMUcJ8ySOdi_vq2AQBc4BmZgkBMGBc4IZcxfjEGPOPpBZmkyFBAlk_JftM47bot1U7VvvftgSrf7mQwmn67vqbW_Yz0pLpf2TvfUW-pD2NONtQP_ZgwNCrZmEhdR-NQySBV3XmnaW1aH0Itt4b2wckmXpFzO4K5PuKMfD49fiyfk_X76mX5sE7UOAyTKi_AIEezyCHjmdVWKSkFGJGlwLkFrVmF3NoUC8WYEAosMwwqyxkrco0zcvffuwt-P5jYl62LyjSN7IwfYglpgYAALButt0frULVGl7vgWhkO5ekm_AN0o2oJ</recordid><startdate>201301</startdate><enddate>201301</enddate><creator>Ilodigwe, Don</creator><creator>Murray, Gordon D</creator><creator>Kassell, Neal F</creator><creator>Torner, James</creator><creator>Kerr, Richard S C</creator><creator>Molyneux, Andrew J</creator><creator>Macdonald, R Loch</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201301</creationdate><title>Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials</title><author>Ilodigwe, Don ; Murray, Gordon D ; Kassell, Neal F ; Torner, James ; Kerr, Richard S C ; Molyneux, Andrew J ; Macdonald, R Loch</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1453-b571e363e851464fdfccaa91e942166f1dd0b36ff237c0099c1f0e01bf60075d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neuroprotective Agents - therapeutic use</topic><topic>Pregnatrienes - therapeutic use</topic><topic>Randomized Controlled Trials as Topic - statistics &amp; numerical data</topic><topic>Statistics as Topic - methods</topic><topic>Subarachnoid Hemorrhage - drug therapy</topic><topic>Subarachnoid Hemorrhage - surgery</topic><topic>Subarachnoid Hemorrhage - therapy</topic><topic>Treatment Outcome</topic><topic>Vasospasm, Intracranial - drug therapy</topic><topic>Vasospasm, Intracranial - surgery</topic><topic>Vasospasm, Intracranial - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ilodigwe, Don</creatorcontrib><creatorcontrib>Murray, Gordon D</creatorcontrib><creatorcontrib>Kassell, Neal F</creatorcontrib><creatorcontrib>Torner, James</creatorcontrib><creatorcontrib>Kerr, Richard S C</creatorcontrib><creatorcontrib>Molyneux, Andrew J</creatorcontrib><creatorcontrib>Macdonald, R Loch</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurosurgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ilodigwe, Don</au><au>Murray, Gordon D</au><au>Kassell, Neal F</au><au>Torner, James</au><au>Kerr, Richard S C</au><au>Molyneux, Andrew J</au><au>Macdonald, R Loch</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials</atitle><jtitle>Journal of neurosurgery</jtitle><addtitle>J Neurosurg</addtitle><date>2013-01</date><risdate>2013</risdate><volume>118</volume><issue>1</issue><spage>3</spage><epage>12</epage><pages>3-12</pages><eissn>1933-0693</eissn><abstract>In randomized clinical trials of subarachnoid hemorrhage (SAH) in which the primary clinical outcomes are ordinal, it has been common practice to dichotomize the ordinal outcome scale into favorable versus unfavorable outcome. Using this strategy may increase sample sizes by reducing statistical power. Authors of the present study used SAH clinical trial data to determine if a sliding dichotomy would improve statistical power. Available individual patient data from tirilazad (3552 patients), clazosentan (the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage trial [CONSCIOUS-1], 413 patients), and subarachnoid aneurysm trials (the International Subarachnoid Aneurysm Trial [ISAT], 2089 patients) were analyzed. Treatment effect sizes were examined using conventional fixed dichotomy, sliding dichotomy (logical or median split methods), or proportional odds modeling. Whether sliding dichotomy affected the difference in outcomes between the several age and neurological grade groups was also evaluated. In the tirilazad data, there was no significant effect of treatment on outcome (fixed dichotomy: OR = 0.92, 95% CI 0.80-1.07; and sliding dichotomy: OR = 1.02, 95% CI 0.87-1.19). Sliding dichotomy reversed and increased the difference in outcome in favor of the placebo over clazosentan (fixed dichotomy: OR = 1.06, 95% CI 0.65-1.74; and sliding dichotomy: OR = 0.85, 95% CI 0.52-1.39). In the ISAT data, sliding dichotomy produced identical odds ratios compared with fixed dichotomy (fixed dichotomy vs sliding dichotomy, respectively: OR = 0.67, 95% CI 0.55-0.82 vs OR = 0.67, 95% CI 0.53-0.85). When considering the tirilazad and CONSCIOUS-1 groups based on age or World Federation of Neurosurgical Societies grade, no consistent effects of sliding dichotomy compared with fixed dichotomy were observed. There were differences among fixed dichotomy, sliding dichotomy, and proportional odds models in the magnitude and precision of odds ratios, but these differences were not as substantial as those seen when these methods were used in other conditions such as head injury. This finding suggests the need for different outcome scales for SAH.</abstract><cop>United States</cop><pmid>23039145</pmid><doi>10.3171/2012.9.JNS111383</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 1933-0693
ispartof Journal of neurosurgery, 2013-01, Vol.118 (1), p.3-12
issn 1933-0693
language eng
recordid cdi_proquest_miscellaneous_1273131104
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adult
Aged
Aged, 80 and over
Female
Humans
Male
Middle Aged
Neuroprotective Agents - therapeutic use
Pregnatrienes - therapeutic use
Randomized Controlled Trials as Topic - statistics & numerical data
Statistics as Topic - methods
Subarachnoid Hemorrhage - drug therapy
Subarachnoid Hemorrhage - surgery
Subarachnoid Hemorrhage - therapy
Treatment Outcome
Vasospasm, Intracranial - drug therapy
Vasospasm, Intracranial - surgery
Vasospasm, Intracranial - therapy
title Sliding dichotomy compared with fixed dichotomization of ordinal outcome scales in subarachnoid hemorrhage trials
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T04%3A40%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sliding%20dichotomy%20compared%20with%20fixed%20dichotomization%20of%20ordinal%20outcome%20scales%20in%20subarachnoid%20hemorrhage%20trials&rft.jtitle=Journal%20of%20neurosurgery&rft.au=Ilodigwe,%20Don&rft.date=2013-01&rft.volume=118&rft.issue=1&rft.spage=3&rft.epage=12&rft.pages=3-12&rft.eissn=1933-0693&rft_id=info:doi/10.3171/2012.9.JNS111383&rft_dat=%3Cproquest_pubme%3E1273131104%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1273131104&rft_id=info:pmid/23039145&rfr_iscdi=true